Virginia Cannabis News

Virginia Gov.-elect Abigail Spanberger's commitment to launching adult-use cannabis sales is expected to create a significant opportunity for the legal industry, anticipating hundreds of permits and billions in sales.

The newsletter covers several topics related to cannabis and psychedelics, including a Gallup poll showing a slight dip in marijuana legalization support, driven by Republicans. It also highlights the pro-legalization stances of incoming governors in Virginia and New Jersey, a study on cannabis drinks reducing alcohol use, and a review on the "surged" use of psilocybin. Other updates include state and local legislative and regulatory actions, international news, and business reports from cannabis companies.

Abigail Spanberger (D), a former Congresswoman and CIA officer, was elected as Virginia's governor, defeating Republican Winsome Earle-Sears. She succeeds Republican Glenn Youngkin, who had blocked adult-use cannabis sales. Spanberger, who has an 'A' grade from NORML, promised during her campaign to allow adult-use cannabis sales and work with the General Assembly to create a legalized retail market focused on public safety and economic growth. In Congress, she supported the SAFE Banking Act and legislation to remove cannabis from the Controlled Substances Act, and allow states to set their own policies.

The election of Democratic candidate Abigail Spanberger as Virginia's governor is seen as positive for the cannabis industry, signaling the potential launch of an adult-use cannabis market in Virginia, despite bans passing in other locations.

Mikie Sherrill, the incoming governor of New Jersey, supports legalizing home cultivation of marijuana, a policy reform long awaited by consumers and advocates. Her priorities also include preventing youth access to THC products, effectively distributing tax revenue, and addressing the lack of a home grow option. Current Governor Phil Murphy opposes home cultivation at this time. During her time in Congress, Sherrill voted in favor of federal legalization and social equity bills, supported federal rescheduling of marijuana, and consistently backed the SAFE Banking Act. She has also worked on defense legislation amendments related to cannabis use waivers and drug conviction expungements.

Abigail Spanberger, Virginia's newly elected Democratic governor, supports legalizing adult-use marijuana sales, a change from the outgoing Republican governor, who had vetoed previous attempts. Spanberger emphasizes the need for a safe, transparent, and fair retail market, with revenue reinvested in communities like public schools. Use and possession of marijuana are currently legal in Virginia, but retail sales are banned, fueling an illicit market. Spanberger defeated Lt. Gov. Winsome Earle-Sears, who had opposed the reform. With an expanded Democratic majority in the legislature, advocates believe the state now has the opportunity to establish a regulated adult-use cannabis market, with legislative commissions already working on a proposal for the 2026 session.

The newsletter details updates on federal and state cannabis policy, including the Supreme Court delaying a marijuana and gun rights case, the failure of an Oklahoma legalization effort, and Massachusetts advancing a cannabis bill to study legal barriers for first responders. It also mentions alcohol groups urging Congress to ban intoxicating hemp products and former White House staffers discussing federal marijuana rescheduling and pardons. Other topics include state-level legislative updates, studies on CBD and psilocybin, and business/financial news from cannabis and related companies.

D.C.'s medical cannabis sales were $7.8 million in September, down 5% from August, but manufacturing, concentrate, and infused product sales showed strong growth, with out-of-District patients from Maryland, Virginia, and Florida as key buyers. Maryland provided a $217,000 grant for cannabis workforce training, police paused the "Green Lab" study due to high volunteer interest, and Virginia's unestablished retail cannabis market is becoming a focus ahead of the gubernatorial race, coinciding with a new online training program for healthcare professionals.

A Virginia medical cannabis company, Dalitso LLC (Hello Cannabis Dispensary), has sued DoorDash, Total Wine & More, and other distributors, alleging they conspired to sell "intoxicating cannabinoid products" disguised as legal hemp. The lawsuit claims Total Wine sold a product with a THC concentration (5.65 mg) exceeding Virginia's 2-milligram hemp limit, and DoorDash delivered it, giving the defendants an "unlawful economic advantage" over licensed dispensaries. Dalitso is seeking $20 million in damages, triple damages under the business-conspiracy statute, and court orders to stop unlicensed cannabis deliveries.

Actor and cannabis brand owner Seth Rogen believes the push to ban or restrict THC beverages is a sign that the market is "threatened," but he expects the hemp drink market to grow due to consumer demand. He sees THC drinks as a good entry-level product and argues that cannabis should be as easy to purchase as alcohol. Rogen also commented on the evolving public perception of cannabis, noting how stigmas are dissolving as people question the original reasons for its prohibition. Additionally, he discussed his role in advocating for cannabis reform.

The summary highlights several marijuana-related news items: negotiations on federal hemp policy; complaints of misleading claims by petitioners seeking to roll back cannabis legalization in Massachusetts; a lawsuit by a Florida legalization campaign against state officials for not advancing their ballot initiative; gun rights groups urging the Supreme Court to expand its review of the federal firearm ban for marijuana consumers; a poll showing cannabis consumers favor Target's sale of hemp-derived THC drinks; updates on state-level legislation and enforcement actions; and a decline in drug crime in Canada attributed to marijuana legalization.

The newsletter covers the DEA promoting an ad campaign blaming fentanyl-laced marijuana for overdose deaths, Ohio's Senate rejecting changes to a marijuana and hemp bill, Maine activists filing a ballot measure to recriminalize some aspects of marijuana, and Pennsylvania leaders meeting with Mike Tyson about cannabis legalization. Other updates include studies on cannabis and sleep/health, various state regulatory and legal developments, and business news such as Cybin Inc.'s common share offering.

In September, D.C.'s medical cannabis sales totaled $7.8 million, a 5% drop from August due to a seasonal slowdown, although manufacturing, concentrate, and infused product sales showed strong growth, with Maryland, Virginia, and Florida patients being top buyers. Regional developments included a $217,000 Maryland grant for cannabis workforce training, a temporary pause in a police-run cannabis impairment study due to high volunteer response, renewed focus on Virginia's unestablished retail market ahead of the gubernatorial race, and the launch of a new online training program for healthcare practitioners.

The summary covers several cannabis-related developments, including a lawsuit against DoorDash and Total Wine & More over alleged Virginia hemp law violations; the New Hampshire House approving a marijuana legalization bill; high support for recreational and medical marijuana legalization in a Kansas poll; the Omaha Tribe of Nebraska approving its first marijuana operation license; a study suggesting greater cannabis retail access may reduce heavy alcohol use; and an Ohio judge extending a temporary pause on the ban of intoxicating hemp products. It also touches on federal and state regulatory updates, international progress, and health studies.

A subsidiary of Jushi Holdings Inc., a multi-state marijuana company, is suing DoorDash, Total Wine, and several other businesses in Virginia for allegedly selling hemp-derived cannabis products that violate state laws by exceeding the legal THC limit (2 milligrams per package). The lawsuit claims the defendants are engaged in a scheme to undermine Virginia’s regulated medical cannabis market by selling unregulated and illegally potent products. Jushi is seeking over $80 million in damages. The legal challenge comes as Virginia and Congress grapple with regulations surrounding intoxicating hemp cannabinoid products.

(Newsletter: October 28, 2025)

A bipartisan coalition of 39 state and territory attorneys general is urging Congress to clarify the federal definition of hemp in the 2018 Farm Bill and impose regulations to prevent the sale of intoxicating cannabinoid products, arguing that the current interpretation has been exploited to sell synthetic THC products, often marketed to minors. They are asking for legislative changes to make these products illegal. Industry stakeholders, however, express concern that a ban could jeopardize the entire hemp market and suggest a middle-ground approach with age-gating and safety standards. Separately, Senator Rand Paul (R-KY) is advocating for a study into state regulatory models and has proposed legislation to triple the legal THC concentration for hemp, opposing efforts by Senator Mitch McConnell (R-KY) to champion criminalization language.

The National Association of Attorneys General (NAAG), representing 39 state and territory attorneys general, sent a letter to Congress seeking clarification on the federal definition of hemp in the 2018 Farm Bill. The letter argues that the growing market for hemp-derived THC products is based on a misinterpretation of the law and asks Congress to clarify the definition of hemp to ensure these "harmful products are illegal."

The summary covers several topics, including a Supreme Court case delay on marijuana and gun rights, an Ohio grant for psychedelic education, a whiskey company scaling back due to a shift towards alternatives like marijuana, and a study linking marijuana use to a reduced risk of alcohol-associated liver disease. It also notes West Virginia refusing to allocate medical cannabis revenue and various state-level updates on cannabis legislation and regulation.

West Virginia's medical cannabis program has collected approximately $34 million in taxes and fees since 2021, which state law requires be used for a medical cannabis research program, substance use disorder resources, and law enforcement training. However, the money remains unspent because cannabis is illegal at the federal level, and traditional banks refused to hold the funds. The money is currently held by a credit union, and the treasurer's office states it will remain unallocated until federal law changes. Other states with legal cannabis markets are spending their tax revenue. Lawmakers who drafted the original legislation expressed surprise that the funds are stockpiling. If the money were distributed today, it would be allocated to public health, substance abuse programs, and law enforcement training.

A new study found that frequent marijuana use, particularly among those meeting the criteria for "cannabis use disorder" (CUD), is associated with a reduced risk of developing alcohol-associated liver disease (ALD) compared to both infrequent users and non-users. The researchers theorize that the non-intoxicating cannabinoid CBD may be responsible for this protective effect, and suggest that the cannabinoid system could be a promising therapeutic target for ALD. The study found a 40% reduction in the composite ALD, a 17% reduction in hepatic decompensation, and a 14% reduction in all-cause mortality associated with cannabis use.

The West Virginia Treasurer’s Office is withholding about $34 million collected since 2021 from the state's medical cannabis industry until changes in federal law occur. State officials and legislators, including those who wrote the cannabis banking legislation, were reportedly unaware the funds were unspent. The funds are legally required to establish a medical cannabis research program, provide resources for substance use disorder, and fund law enforcement training, none of which have been created or funded due to the money being held. If distributed, the funds would be allocated to the Bureau for Public Health ($19 million), the Fight Substance Abuse Fund ($8 million), the Division of Justice and Community Services ($6 million), and law enforcement training ($1.5 million).

D.C. dispensaries face oversupply, reducing sales. A court ruling set a precedent against nuisance marijuana smoking. Illegal operations like Tobacco King & Vape and Mother Earth Mushroom Church were shut down. Maryland police started the "Cannabis Green Lab" for impairment research. Virginia license applicants face tough competition and regulations.

Ohio House lawmakers approved an amended Senate-passed bill that significantly alters the state's voter-approved marijuana legalization law and introduces new regulations for hemp, aiming to align the two sectors. The bill includes same potency and advertising restrictions for hemp as marijuana, permits the sale of hemp-derived THC beverages (with limits on THC content and new taxes), and restricts where intoxicating hemp products can be sold to licensed dispensaries. Controversial provisions remain, such as the elimination of anti-discrimination protections for cannabis users and the recriminalization of possessing marijuana not sourced from a state-licensed dispensary or home grow. Advocates are concerned the bill rolls back voter-enacted freedoms. Unlike the Senate version, the House substitute will send tax revenue from cannabis sales to local governments. The bill also includes a process for expunging prior cannabis possession convictions.

Ohio House lawmakers are set to revise the state's voter-approved marijuana legalization law, primarily by focusing the proposal on regulating intoxicating hemp products and scaling back controversial restrictions on the marijuana market. The legislation, using Senate Bill 56 as a vehicle, will still address the recreational marijuana program, including tax revenue allocation. Under a planned amendment, stores and breweries could sell THC beverages, but high-THC hemp products would be temporarily banned while rules are developed. The effort to regulate hemp follows a blocked executive order to ban intoxicating hemp products. Lawmakers, including Rep. Jamie Callender, believe combining marijuana and hemp regulations in the bill may compel the Senate to accept the House's preferred marijuana provisions. Meanwhile, the Ohio Department of Cannabis Control (DCC) has also filed new proposed rules regarding labeling and packaging for the existing marijuana market, which has already seen over $3 billion in sales.

In D.C., Chocolate City Wellness was suspended for 30 days due to illegal cannabis sales. In Maryland, three social equity licensees (Koan Cannabis, Elevated Dispo, and Elevated Releaf) received operational licenses. In Virginia, small cannabis businesses voiced concerns about regulatory fairness.

Sara Carter Bailey, President Trump’s nominee to serve as director of the
White House Office of National Drug Control Policy, dodged senators’
written questions about marijuana rescheduling—saying only that she would
“ensure an examination of all facts and evidence as part of any scheduling
or policy actions.”

During a Virginia gubernatorial debate, candidates Abigail Spanberger (D) and Winsome Earle-Sears (R) debated marijuana policy. Spanberger supports legalization with transparency and public safety, advocating for revenue to be reinvested into communities and public schools. Earle-Sears supports medicinal marijuana but opposes a commercial market, citing concerns about employee drug use in her utility repair business and calling marijuana a gateway drug. Virginia legalized possession and cultivation in 2022, but retail sales are still forbidden due to Governor Glenn Youngkin's vetoes. A legislative commission is working on a proposal for commercial sales to be considered in the 2026 session, with some senators pushing for legalization as an alternative revenue source.

A key Senate committee has given initial approval to President Donald
Trump’s pick to serve as White House drug czar, where she will play a
central role in implementing the administration’s drug policy agenda that
touches on everything from marijuana and psychedelics to harm reduction and
overdose prevention.

The D.C. Council extended conditional medical cannabis licenses by 12 months for new operators. Other news includes highlights from the Oct. 8 ABC Board meeting, four unlicensed retailer closures, Maryland’s social equity vendor fair and incubator launch, and Virginia’s 2026 retail cannabis roadmap discussions.

At Stone Brewing in Richmond, the after-hours crowd of small cannabis entrepreneurs looked like a support group that had just survived an ambush. Hours earlier, many of them sat through a General Assembly session meant to gather community input on Virginia’s long-awaited framework for adult-use cannabis sales. But by the end of the hearing, it didn’t feel like the community had been heard, it felt like maybe the verdict was already written...

The article discusses the issue of "inversion" in New York's cannabis market, where cannabis from oversupplied states like California and Michigan is falsely sold as locally produced. This practice, known as Croptober, is becoming increasingly prevalent due to weak oversight and delayed implementation of tracking systems. The article explains how inversion works through fake harvest reports and inflated extraction yields, leading to consumer distrust and an unstable market. It proposes solutions for New York, including routine audits, surprise inspections, structural reforms like canopy caps, and consumer-facing accountability through product labels. The author, Damian Fagon, emphasizes that state-level reforms are crucial, but a national imbalance created by oversupplied states also needs to be addressed.

The Drug Enforcement Administration said in a new filing that the marijuana
rescheduling appeal process is still on hold and “remains pending” before
Administrator Terrance Cole, who previously pledged that advancing the
issue would be “one of my first priorities.”

A Virginia legislative commission is preparing the state to legalize recreational marijuana sales, with a proposal expected in the 2026 legislative session. While possession and use have been legal since 2022, retail sales are still forbidden due to Governor Youngkin's vetoes. The commission is addressing issues like regulatory considerations, taxes, transitioning from medical to recreational markets, ensuring fair competition, and consumer protection. Experts have emphasized creating an equitable market that benefits local businesses and displaces the illicit market, rather than favoring existing multi-state operators. Future cannabis policy in Virginia will be influenced by the upcoming gubernatorial election, with the two major party nominees holding opposing views on legalizing recreational marijuana sales.

The text discusses various cannabis and drug policy updates from different states and federal levels. Key points include: American basketball player Jarred Shaw facing the death penalty in Indonesia for cannabis gummies, Kentucky's first medical marijuana harvest, Texas banning consumable hemp products for those under 21, New Hampshire considering allowing for-profit cannabis dispensaries, and Michigan adding a new wholesale tax on marijuana. It also mentions a new cannabinoid discovery, a Nebraska senator challenging medical cannabis rules, and an Ohio bill to ban intoxicating hemp products for those under 21. Federal updates include inquiries into drug smuggling, DEA agent profiles, and progress on House bills to reschedule marijuana and designate psychedelic therapy centers. State-specific news includes Florida's investigation into Medicare funds for anti-marijuana campaigns, Ohio legalizing drug testing strips, Wisconsin restricting hemp products, Virginia's Supreme Court ruling on marijuana impairment in court, Illinois cannabis plant tracking rule changes, and events in Oregon, Maine, and New York related to cannabis and psychedelics. Scientific findings highlight cannabis-based products for pain and psilocybin for depression. Opinion pieces include a drop in Ohio marijuana consumer satisfaction and a Fox News host's controversial tweet about cannabis. Business news covers Vireo Growth Inc.'s acquisition and Green Check's new platform.

D.C. regulators ordered the Temple of Golden Teacher to close due to psilocybin sales, while DC Smoke's license was upheld. ABCA issued fines and made arrests related to unlicensed dispensaries. In Maryland, THC regulation enforcement was restored, and Virginia is launching a safe driving campaign.

The provided text summarizes a "Marijuana Moment" newsletter from September 30, 2025. Key points include: the DOJ delaying a marijuana rescheduling challenge, a US citizen freed from Russia over cannabis speaking at a conference, and Ohio marijuana rules changes. It also covers federal, state, local, international, science & health, advocacy, and business news related to cannabis.

*DOJ moves to dismiss marijuana & guns case; Lawmakers push against hemp
criminalization; MI cannabis tax increase; Study: CBD & anxiety*

*MN’s 1st marijuana event license; KY hemp farmer letter to McConnell;
Study: Anti-rescheduling poll; Snapchat AI blocks cannabis info but OKs
alcohol *

Virginia's medical cannabis sales reached nearly $30 million in July and August, exceeding expectations according to state data.

D.C. is considering extending conditional licenses to four years due to ABCA crackdowns. Maryland is recalling bacteria-contaminated edibles. Virginia's medical cannabis sales are surging despite patient concerns.

Flower products are the most popular in Virginia's medical cannabis market, making up 47% of sales. Concentrates account for 32%, edibles for 15%, and shake for 5%. The data comes from the state's new seed-to-sale tracking system, provided by METRC, which launched two months ago. In July and August, the system recorded 17,786 harvested plants, $29,942,138 in sales, and 256,432 transactions. Virginia is one of 23 U.S. states using METRC to track cannabis data. The Cannabis Control Authority plans to create a public dashboard to host the data.

The provided text is a newsletter from "Marijuana Moment" dated September 22, 2025. It covers various cannabis and psychedelics-related news, including: * Virginia gubernatorial candidates' contrasting marijuana positions.
* Rep. Jasmine Crockett calling out Rep. Byron Donalds's past marijuana arrest.
* DOJ's move to dismiss a D.C. cannabis lawsuit.
* Colorado recommending ibogaine be added to psychedelic substances.
* A judge forcing the University of Michigan to allow a psychedelics event.
* Virginia's medical marijuana sales and Delaware's marijuana permit transfers.
* Federal draft legislation to wage war against drug cartels.
* Sen. Rand Paul's tweet against banning hemp.
* Various state-level cannabis and hemp regulatory updates, recalls, and guidance.
* Local news on cannabis cafes and marijuana possession fines.
* International news on regulatory perspectives on psychedelics.
* Science and health studies on cannabinoids and psilocybin.
* Advocacy from the American College of Obstetricians and Gynecologists advising against cannabis use for pregnant and lactating women.
* Business news including a new CEO for LeafLink and Canadian marijuana sales.

The upcoming election has high stakes, from the lack of adult-use dispensary sales in Virginia to a home-grow ban in New Jersey.

Virginia's new seed-to-sale medical cannabis tracking system, operated by the Virginia Cannabis Control Authority (CCA) and Metrc, has been online for two months, providing real-time data on plants, products, and sales. This system helps the CCA track popular products, plant growth, and sales trends, aiming to protect patients and prevent illegal products. Early data shows nearly half of sales were flower, with concentrates, edibles, and shake trim making up the rest. The CCA plans to create a public dashboard for data transparency. Patients continue to express concerns about high prices and limited access, with some traveling to neighboring states for cheaper products. The system's unveiling coincides with a debate in the General Assembly about legalizing recreational cannabis sales, which lawmakers are considering for as early as 2026. The CCA's current focus remains on refining the medical program and ensuring public safety, with the tracking system allowing regulators to trace products and reduce risks.

Virginia's upcoming gubernatorial election will significantly impact the future of recreational marijuana sales in the state, with the two leading candidates holding opposing views. Current Lt. Gov. Winsome Earle-Sears (R) strongly opposes legalization, citing concerns about it being a "gateway drug" and "decimating communities." In contrast, former U.S. Rep. Abigail Spanberger (D-VA) supports establishing a regulated cannabis market, emphasizing public safety, economic growth, and reinvesting tax revenue into communities and public schools. While possession and home cultivation of marijuana have been legal since 2022, retail sales remain forbidden due to Governor Youngkin's vetoes of previous legislative efforts. The new governor will likely determine whether regulated sales become a reality in Virginia.

*GOP senator: Congress must “step up” on marijuana; Dem lawmaker talks
Trump & cannabis; OH’s $3B in sales; Study: cannabis as tobacco substitute*

Pending federal legislation could significantly change the hemp industry by redefining THC limits, excluding synthetic and converted cannabinoids, and potentially imposing a "no quantifiable" THC threshold. These changes would disrupt current business models and create compliance challenges, potentially pushing products to the illicit market. An alternative, more regulatory approach, similar to Rep. Griffith's bill, is also being considered, which focuses on health and safety with specific THC thresholds and labeling requirements. The outcome of these debates will determine the future economic viability of the hemp industry in the United States.

A GOP-controlled House committee has approved a spending bill that contains
provisions to block the Justice Department from rescheduling marijuana.

Dispensary growth in D.C. is causing oversaturation concerns, though tourism helps sales. Trulieve's acquisition of Harvest Health will strengthen its position in Maryland's medical cannabis market. Virginia's retail legalization debate shows a conflict between large operators and small businesses, while new products like THC seltzer indicate the state's move into cannabis beverages.

Kellyanne Conway, a former senior counselor to President Donald Trump, is
the “biggest champion” of marijuana rescheduling within the president’s
“inner circle,” Congressional Cannabis Caucus Co-chair Rep. Brian Mast
(R-FL) told Marijuana Moment.

Former Trump administration Housing and Urban Development Secretary Ben
Carson authored an op-ed arguing that the marijuana rescheduling proposal
the president is currently considering would undermine his push to end “the
crime epidemic destroying American cities.”

The House Rules Committee is set to consider National Defense Authorization
Act amendments to expand waivers for military recruits who’ve tested
positive for marijuana and to allow service members to use legal hemp
products.

The provided text is a newsletter from Marijuana Moment, dated July 24, 2025. Key topics include the retirement of the DEA judge overseeing marijuana rescheduling, comments from the VA Secretary on psychedelics, the DEA's drug emoji guide, Texas Governor Greg Abbott's evolving stance on hemp, a court ruling on cannabis consumers' gun ownership, and the stepping down of the National Cannabis Industry Association CEO...

A new bill in Pennsylvania, SB 926, aims to protect parents who are medical marijuana patients from losing child custody or being subjected to drug tests solely based on their patient status. This legislation, introduced by Sen. John Kane, seeks to clarify existing state law and prevent lawful medical marijuana use from being used against parents in custody disputes. The push for this reform is happening alongside a broader effort to legalize adult-use marijuana in Pennsylvania, with several other bills and proposals currently under consideration, facing bipartisan support and opposition within the legislature.

Pennsylvania House Democrats are urging voters to pressure state senators to pass HB 1200, a bill to legalize marijuana and sell it through state-owned stores, citing health, safety, and revenue benefits. The bill narrowly passed the House but was rejected by a Senate committee. Despite bipartisan support among voters, the reform faces opposition from Senate Republicans. Other legalization proposals are in discussion, and supporters believe growing public sentiment will help overcome legislative hurdles. The governor also supports legalization, emphasizing competitiveness with surrounding states.

Senators Advance Bill Continuing Medical Marijuana Protections And Omitting House Proposal To Block Rescheduling

A Republican Pennsylvania senator, Dan Laughlin, believes that supporters of marijuana legalization are gaining votes to pass reform this session. He states that people prefer legalizing cannabis for revenue rather than increasing taxes to balance the budget. Laughlin, along with Sen. Sharif Street, introduced a bill to legalize adult-use cannabis. There are also other proposals, including a House companion version, under consideration. Despite previous setbacks, lawmakers are optimistic about passing a bill that would also include sealing and expunging cannabis-related convictions. However, there are conflicting views on the model of cannabis sales (state-run vs. private businesses) and the political dynamic with a GOP-controlled Senate. Despite these challenges, polls show strong public support for legalization. The governor also supports legalization, emphasizing economic benefits and public safety.

Trump Signs Fentanyl Criminalization Bill That Could Also Open Up Research On Marijuana, Psychedelics And Other Schedule I Drugs

A Democratic Pennsylvania House lawmaker, Rep. Amen Brown, has filed a new marijuana legalization bill, mirroring a bipartisan Senate proposal. He argues that legalization would expand patient access, strengthen the state's cannabis infrastructure, ensure product safety, combat the black market, and address disproportionate arrests in communities of color. Brown emphasizes the economic benefits, citing other states, and warns against high tax rates that could drive consumers to illicit markets. Other lawmakers have also introduced similar bills, highlighting the bipartisan support and economic opportunities for Pennsylvania. Despite broad public support, legislative efforts have faced hurdles, particularly regarding state-run stores and the need for Republican support in the Senate.

Home values have increased more in states where recreational marijuana is legal compared to where it is illegal. In 2024, the typical home in a recreational state was worth 39% more than in non-recreational states. Similarly, homes in states with legal medicinal marijuana are worth about 18% more than in illegal states. The report also lists the top ten states with the highest and lowest home value increases since 2009, highlighting the correlation with cannabis legalization. Clever Real Estate is the source of this report.

A new study by Clever Offers shows that home values in states where adult-use marijuana is legal have increased by $60,327 more on average between 2009 and 2024 compared to states where it remains criminalized. The report states that recreational cannabis states saw an average home value increase of $222,958, while non-legal states saw an average increase of $162,631. As of 2024, the average house in a legal marijuana state was worth $447,635, about 39% more than the average house price in non-recreational states. The study also found that states with only medical marijuana legalization saw greater home price increases ($22,185 more) than states where cannabis remains outlawed. While legalization is not the sole driver, tax revenue from legal cannabis is reinvested into public programs, making neighborhoods more desirable.

A congressional committee approved a spending bill that includes provisions to block the Justice Department from rescheduling marijuana and maintains protections for state medical cannabis programs, with new language for enhanced penalties for sales near schools. The bill would specifically prevent the Justice Department from using funds to reschedule or deschedule marijuana. The Drug Enforcement Administration's marijuana rescheduling process remains stalled. Separately, discussions around marijuana policy reform and rescheduling efforts continue among politicians and advocates.

A new study in the journal Pharmacy indicates that chronic pain patients who used medical marijuana for at least one year had lower healthcare utilization, including fewer urgent care and emergency department visits, and reported a higher quality of life. The study, involving over 5,000 patients, suggests that medical cannabis is an effective treatment for chronic pain and can lead to positive effects on the healthcare system. Other recent research also supports medical marijuana's role in pain management, its potential to reduce opioid use and related harms, and its cost-effectiveness as an alternative therapy for various conditions.

DMV cannabis news. Source Newsletter.

Bipartisan lawmakers in Pennsylvania have filed new bills to legalize marijuana. The House has filed legislation establishing the Keystone Cannabis Authority and the Community Opportunity Fund, aiming to close a budget gap and create jobs. Meanwhile, a companion bill to a Senate legalization proposal is also expected to be filed in the House. Lawmakers supporting legalization emphasize economic opportunity, justice, equity, and responsible regulation, including expungement of low-level offenses. The governor has called for adult-use marijuana legalization, stressing competitiveness and the need to address the illicit market. Despite bipartisan support among voters, legislative efforts have stalled due to conflicting views, particularly on state-run stores versus private sales, and the need for Republican support in the Senate.

The provided text summarizes a Marijuana Moment newsletter from July 14, 2025. Key topics include accusations of child labor violations against a marijuana business, a congressional amendment for psychedelic medical trials, and a Wisconsin GOP gubernatorial candidate open to marijuana legalization. Other points cover a former NFL player's meeting with White House officials about cannabis rescheduling, a study on psilocybin and ayahuasca improving veterans' mental well-being, and various state-level updates on cannabis regulations and market launches. Federal officials are also discussing immigration raids on cannabis businesses and related political rhetoric.

A bipartisan bill to legalize recreational cannabis in Pennsylvania was introduced by Senators Dan Laughlin and Sharif Street, but it faces opposition from Senate Majority Leader Joe Pittman, who does not see a prevailing view for legalization within the Republican caucus as part of the current budget negotiations. The bill proposes legalizing cannabis for those 21 and over, with a 6% sales tax and 8% excise tax, and would expunge non-violent cannabis convictions. Despite broad Democratic support and calls from Gov. Josh Shapiro, similar measures have struggled to pass the GOP-controlled Senate, particularly due to a previous proposal that would have sold cannabis in state stores, which was a nonstarter for many.

The author, Ryan Basore, a former federal prisoner for medical cannabis cultivation, launched Redemption Cannabis and the Redemption Foundation. His cannabis brand is now available in West Virginia, where he was incarcerated. The Redemption Foundation provides expungements and financial support to non-violent cannabis offenders still in prison, partnering with organizations like Mission Green and the Last Prisoner Project. Basore emphasizes that despite widespread legalization, many people remain incarcerated for cannabis offenses, and federal law, which classifies cannabis as a Schedule I drug, needs to change for true justice. He states that 10% of Redemption Cannabis licensing revenue supports incarcerated individuals and their release, highlighting that buying their products contributes to the pursuit of justice.

Redemption’s flower is sold at the company’s dispensaries, and a portion of each sale is reinvested in communities affected by prohibition.

The provided text is a newsletter from "Marijuana Moment" dated July 11, 2025. Key topics include: a Senate committee approving a delayed ban on consumable hemp products with THC; ICE raids on state-licensed marijuana farms; former House Speaker Newt Gingrich's support for psychedelic therapy; Texas Gov. Greg Abbott's opposition to a blanket hemp prohibition; California's advancement of cannabis tax reform; Delaware lawmakers seeking feedback on recreational cannabis sales; and a federally funded study finding THC-dominant medicinal cannabis reduces anxiety and depression. Other sections cover federal and state news, local developments, international cannabis policies, science and health studies, advocacy opinions, and business updates in the cannabis industry.

Bipartisan Pennsylvania Senators Dan Laughlin (R) and Sharif Street (D) have filed a bill to legalize adult-use marijuana in the state. The legislation aims to create a Cannabis Control Board, protect consumers, expunge past offenses, and reinvest in communities impacted by prohibition. Supporters highlight the economic benefits and the need for Pennsylvania to catch up with neighboring states that have already legalized cannabis. While there is bipartisan support among voters, the reform has faced legislative hurdles, particularly in the GOP-controlled Senate. Governor Josh Shapiro (D) has also called for legalization, emphasizing the economic advantages and the need to regulate the illicit market.

This newsletter from Marijuana Moment on July 10, 2025, covers various cannabis-related news. Key topics include an Oklahoma legalization ballot measure, Hawaii's governor signing a hemp bill, California's marijuana decriminalization 50th anniversary, and a study on Pennsylvania's medical cannabis and anxiety. Other updates include Virginia's cannabis commission planning legal sales, Alabama's stalled medical cannabis licensing, and differing hemp legislation in North Carolina. Federal news covers Customs and Border Protection blocking a man due to marijuana offenses, and Rep. Thomas Massie citing hemp legalization. State news includes California allocating marijuana revenue to combat impaired driving, Florida removing illegal hemp products, Ohio Republicans opposing efforts to undermine legalization, and Colorado regulators sending a bulletin about revoked marijuana licenses. International news mentions a Canadian senator joining an Australian drug policy reform organization. Science and Health sections highlight a review on nano-CBD platforms and a study on psilocybin for depression in veterans. Business news includes Auxly Cannabis Group Inc. closing debt reduction transactions and Canopy Growth Corporation having a new interim chief financial officer. The newsletter encourages subscriptions and support via Patreon.

A newly re-established cannabis commission in Virginia held its first meeting to discuss the future of marijuana in the commonwealth. The commission aims to create a successful approach to cannabis rooted in public protection, restorative justice, economic equity, and public health, with the goal of crafting a bill to legalize retail sales. Despite marijuana use being legal since 2022, retail sales are forbidden due to Governor Glenn Youngkin's vetoes. The commission will gather public input and make recommendations, with future meetings scheduled through 2028. Key goals include generating revenue for community reinvestment, creating small businesses, strengthening agriculture, addressing racial inequities, protecting public health, and increasing funding for pre-K education.

This newsletter from Marijuana Moment covers various cannabis and psychedelics-related news. Key topics include a federal judge upholding a gun ban for marijuana users, a former Navy SEAL discussing psychedelic therapy for PTSD, and a scientific review on what gives cannabis strains their aroma and flavor. It also highlights a study on cannabis consumption in California, Maryland's plan for a state-owned cannabis incubator, and updates on cannabis legislation and regulation in several states. Other sections touch on international drug policy, science and health studies related to cannabis and psychedelics, and business news in the cannabis industry.

A Navy SEAL veteran, Rob O’Neill, known for killing Osama Bin Laden, states that psychedelic therapy has helped him with PTSD and believes it should be a readily available treatment option for veterans in the U.S. He uses ibogaine in Mexico annually to manage his symptoms, emphasizing that it works better than alcohol for trauma. Various organizations are assisting veterans in accessing psychedelic treatments abroad, and there's a growing push for domestic access, with bipartisan congressional support and commitment from federal agencies like HHS and VA to expand research and access to substances like MDMA, ibogaine, and psilocybin for military veterans.

New York-based Cannabis Public Policy Consulting LLC was awarded a $238,700 contract to study Missouri's marijuana market for the next year. The study aims to determine if and when the state needs to issue additional cannabis facility licenses, and to provide information on the economic stability of the regulated market, including its impact on economically distressed areas. Missouri's cannabis market has been successful, with $1.46 billion in sales in 2024, partly due to limiting the number of licenses. The study will also help create a plan to promote ownership and employment in the marijuana industry for people from economically distressed areas.

Summary: D.C., Virginia and Maryland cannabis news from June 25 to July 1, 2025.

The July 2, 2025, Marijuana Moment newsletter covers various cannabis-related news. Key topics include the Virginia commission preparing for legal recreational sales, Florida's governor signing a bill to revoke medical cannabis registrations for certain drug crimes, Pennsylvania senators filing a bill for a Cannabis Control Board, and Delaware announcing recreational sales will begin on August 1. Other updates include federal discussions on cannabis and psychedelics, state-level changes in marijuana taxes and regulations, and scientific studies on CBD and psychedelic-assisted therapy. The newsletter also mentions business news, such as Trulieve Cannabis Corp. filing a shelf registration and TerrAscend Corp. exiting the Michigan market.

Nebraska Gov. Jim Pillen has approved emergency rules for licensing medical cannabis establishments, with licensing to begin by October 1. The regulations were imposed by voters last November, legalizing medical cannabis with a healthcare practitioner's recommendation. The Nebraska Medical Cannabis Commission will regulate the new medicine. The rules set criteria for licenses (cultivator, manufacturer, dispensary, transporter), including ownership, fingerprinting, location restrictions, and prohibited persons. Dispensaries are limited to one per judicial district and can sell specific products like oral tablets, tinctures, gels, and patches, but not raw plant, edibles, or products for smoking/vaping. Public feedback on the emergency regulations is open until July 15. Advocates have expressed concerns about the ban on whole-plant cannabis and restrictions on usage methods. Formal regulations are expected to follow the emergency guidelines.

Delaware's adult-use marijuana market will launch on August 1, 2025, after delays due to FBI background check issues. The state will issue 125 licenses, including for retailers, cultivators, manufacturers, and testing labs, with portions reserved for social equity applicants and microbusinesses. Governor Matt Meyer celebrated the new industry, highlighting its potential to generate revenue and create opportunities. The state's medical marijuana program also saw significant expansion in July, allowing doctors to recommend cannabis for any condition and enabling patients over 65 to self-certify.

A new Virginia government cannabis commission will meet next week to discuss future marijuana laws, likely leading to a revised proposal for retail sales. While marijuana use and possession have been legal since 2022, retail sales are still forbidden, fueling an illicit market. Governor Glenn Youngkin has twice vetoed proposals for regulated sales, but with his term ending, the next governor will likely decide the fate of retail cannabis. The commission, in place until mid-2028, will gather public input and make recommendations on various policy matters for Virginia's transition to a commercial adult-use market, including licensing, taxes, employment protections, and labor union agreements. Advocacy groups like Marijuana Justice and NORML plan to participate, while the Virginia Cannabis Association does not, focusing instead on reintroducing previously vetoed legislation. The outcome of the upcoming gubernatorial election is seen as crucial for the future of cannabis retail in Virginia.

Pennsylvania senators have introduced a bipartisan bill to create a new regulatory body, the Cannabis Control Board (CCB), to oversee medical cannabis and prepare for eventual adult-use legalization. The bill, sponsored by Senator Dan Laughlin, aims to establish a transparent and efficient framework for the cannabis industry, ensuring the state is ready when adult-use legalization passes. The CCB would consolidate oversight, enhance transparency, and manage the industry. While the bill doesn't explicitly legalize adult-use cannabis, it sets up the infrastructure for it. Democrats and some Republicans support legalization due to public health and safety concerns, economic benefits, and competitiveness with neighboring states that have already legalized. Despite bipartisan voter support, the reform faces hurdles in the legislature due to conflicting views on a state-controlled versus private sales model and the need for Republican support in the GOP-controlled Senate.

White House Announces Withdrawal Of Trump’s Drug Czar Nominee Who Embraced Medical Marijuana

* GOP senator: Regulate marijuana like alcohol; Bill to increase hemp THC limit; Survey: Cannabis industry workers happy; OH legalization change delay.
* The U.S. House of Representatives approved amendments to let Department of Veterans Affairs doctors recommend medical cannabis and to support research on the therapeutic benefits of psychedelics.
* Sen. Thom Tillis (R-NC) said marijuana legalization opponents “have lost” the debate and that “it’s time” to create a regulatory framework treating cannabis “the same way that we do with alcohol and tobacco” so states can set their own policies without federal intervention.
* Sen. Rand Paul (R-KY) filed a bill to triple the amount of THC that can legally be in hemp and to make other changes to federal rules for the crop to address industry concerns.
* Hourly workers in the marijuana industry rank at the top of the list of “happiest” employees across multiple sectors, according to a new survey from Deputy—with more than 9 in 10 reporting a “positive sentiment” in their job.
* Thailand’s public health minister signed an order requiring people to have doctors’ prescriptions and medical certificates mandatory in order to buy cannabis.
* A study found that “since 2012, there has been considerable growth in patents and publications related to cannabis drug delivery systems, driven by the therapeutic potential of cannabinoids.”
* A poll found that Australians support legalizing marijuana, 48 percent to 41 percent.
* Verano Holdings Corp. is opening a bodega-style dispensary in Phoenix, Arizona.

D.C., Virginia, and Maryland cannabis news from June 18 to June 24, 2025.

* Federal hemp ban advances.
* RFK wants psychedelics available in 12 months.
* Pennsylvania legalization debate.
* Montana governor vetoes tribal cannabis bill.
* Texas hemp regulations.
* The House Appropriations Committee approved a spending bill containing provisions to ban most consumable hemp-derived cannabinoid products.
* The House Rules Committee cleared amendments to let Department of Veterans Affairs doctors recommend medical cannabis and to support research on the therapeutic benefits of psychedelics for floor votes this week.
* Texas’s lieutenant governor decided to ban all synthetic cannabis including Delta 8, Delta 10, and others.
* A review concluded that purified cannabidiol was reported to reduce seizure frequency ranging between 30% and 50%.
* Tilray Brands, Inc. announced that it is the first company to receive authorization from Italian officials to import and distribute medical cannabis flower for therapeutic use.

Bloom Brand, a U.S. leader in cannabis vape, is expanding internationally with a launch in the UK in Q1 2026 through a partnership with New Garden Pharma. This marks Bloom's first international market expansion, with plans for further EU market development in 2026 and beyond. The partnership will provide UK patients access to Bloom's vape collections. New Garden Pharma will lead the UK entry, ensuring a compliant and scalable launch.

A key Pennsylvania senator is working with lawmakers to develop a marijuana legalization bill before the budget deadline. The senator stated they are getting close to passing a bill and want to ensure it is equitable. Other lawmakers are also emphasizing the revenue-generating potential of legalization. While some are hopeful, the Senate Majority Leader said legalization will not be included in the 2026 budget.

The provided text is a newsletter from Marijuana Moment. Key topics include: a clash between Texas Gov. Greg Abbott and Lt. Gov. Dan Patrick over hemp regulation; a poll showing support for marijuana reform among US voters; a DEA judge's decision on psychedelic compounds; and a Supreme Court case regarding marijuana users' gun rights. The newsletter also covers state and local news, international developments, and scientific studies related to cannabis.

State legislatures considered criminal justice reform bills related to marijuana, but many failed. The Last Prisoner Project (LPP) calls this the "hidden crisis in cannabis reform." Bills to seal records and release incarcerated individuals fell short in several states. Virginia's resentencing bill was vetoed. However, Maryland and Hawaii saw landmark victories in record relief and expungement. LPP advocates for addressing past drug war harms and urges action on cannabis justice.

A Pennsylvania Republican says marijuana legalization will not be included in the 2026 budget, but Gov. Josh Shapiro hopes for a compromise. The budget deadline is June 30. Shapiro supports legalization, as do many Pennsylvanians, but Senate Republicans are resistant. The House passed a legalization bill, but it was rejected by a Senate committee. Lawmakers are divided, but some are aiming for a compromise. A recent poll shows majority support for legalization. The governor emphasizes the state is "losing out" to others that have already enacted adult-use legalization.

VA Secretary Doug Collins visited a psychedelics research center, emphasizing his commitment to exploring therapeutic benefits for veterans. He discussed policy changes and congressional support, highlighting ongoing clinical trials with MDMA and psilocybin. Collins also mentioned a meeting with HHS Secretary Robert F. Kennedy Jr. and support for vouchers for psychedelic therapy.

Washington, D.C. is cracking down on unlicensed cannabis businesses. Maryland collected over $17.5 million in cannabis taxes in Q1 2025. The owner of Zarati shops in Virginia reached a plea deal in a drug and money laundering case.

*TX gov on hemp ban; FL medical marijuana patient penalty; OR appealing cannabis labor ruling; Petition on Facebook’s drug censorship; AK psychedelics*

GOP senators filed a bill to increase penalties for marijuana edibles; Wisconsin may legalize marijuana; Capitol Hemp is suing the federal government; a Colorado healing center administered the first psilocybin session; Snoop Dogg launched a new cannabis platform.

A coalition of Republican senators have reintroduced a bill that would increase criminal penalties for a wide range of offenses, including manufacturing or selling Schedule I drugs like marijuana in the form of candy or beverages if there is “reasonable cause to believe” they will be sold to minors. The bill targets substances in Schedule I or II of the federal Controlled Substances Act (CSA), including cannabis. The legislation doesn’t explicitly mention marijuana, but a section-by-section analysis says that manufacturers and traffickers of marijuana edibles and fentanyl and other illicit drugs are marketing and distributing these highly dangerous drugs as packaged candy. If enacted, people who are federally prosecuted for such criminal activity could face up to 10 additional years in prison for a first offense if the cannabis product sold to a person under 18 was shaped or flavored like candy. Second and subsequent offenses would carry up to 20 additional years in prison.

Congress sent President Donald Trump a bill to permanently ban fentanyl
analogues—including additional provisions that Rep. Morgan Griffith (R-VA)
says would remove barriers to research on marijuana and other Schedule I
drugs...

Iowa Gov. Kim Reynolds vetoed a bill allowing doctors to prescribe psilocybin upon federal approval. The bill, HF 383, would have reclassified a form of psilocybin, but Reynolds cited concerns about state readiness and legal uncertainty. Lawmakers also considered a broader psilocybin bill, HF 978, which has not advanced.

Congress passed a bill banning fentanyl analogues, but also allowing more research into marijuana and other Schedule I drugs. The House approved the HALT Fentanyl Act, which streamlines research into Schedule I drugs like marijuana, but critics worry it will increase mandatory minimum sentences. The bill also aims to expedite registrations for studies into Schedule I drugs.

Easyday Edibles’ Vision, Proposed Craft Endorsements, and the Harris Rider lives...